Patrick A. Singleton
9Patents
2h-index
4Co-inventors
40Inventor score
Filing activity: Mar 7, 2006 → Nov 16, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9526723B2 | Treatment with opioid antagonists and mTOR inhibitors | Human Necessities | 7 | Active |
| US8518962B2 | Use of opioid antagonists | Physics | 6 | Active |
| US8685995B2 | Treatment with opioid antagonists and mTOR inhibitors | Human Necessities | 2 | Active |
| US8524731B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 1 | Active |
| US10383869B2 | Treatment with opioid antagonists and mTOR inhibitors | Human Necessities | 0 | Active |
| US9675602B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 0 | Active |
| US9662390B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 0 | Expired |
| US9717725B2 | Use of opioid antagonists | Physics | 0 | Active |
| US9662325B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.